Annovis Bio

Annovis Bio Finalizes Phase III Study of Buntanetap in Early Parkinson’s Treatment, Awaits Topline Data

BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) has recently announced the completion of the last patient visit in its phase III study of buntanetap, a leading candidate for treating …

Annovis Bio Finalizes Phase III Study of Buntanetap in Early Parkinson’s Treatment, Awaits Topline Data Read More

TELA Bio

TELA Bio Features in MedTech Europe’s Film Series, Showcasing OviTex Reinforced Tissue Matrix in Hernia Repair

MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a Pennsylvania-based medical technology company, recently announced its participation in the Connecting the Dots series. This collection of branded films is presented …

TELA Bio Features in MedTech Europe’s Film Series, Showcasing OviTex Reinforced Tissue Matrix in Hernia Repair Read More
Teleflex Incorporated

Teleflex Scores Peripheral Access Purchasing Agreement with Premier, Inc., Expanding Reach of Innovative Vascular Products

WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies, recently announced a new Peripheral Access purchasing agreement with Premier, Inc. This agreement, effective from December 1, …

Teleflex Scores Peripheral Access Purchasing Agreement with Premier, Inc., Expanding Reach of Innovative Vascular Products Read More